Two Sigma Securities’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-31,553
| Closed | -$2.83K | – | 2299 |
|
2023
Q3 | $2.83K | Sell |
31,553
-27,756
| -47% | -$2.49K | ﹤0.01% | 1279 |
|
2023
Q2 | $5.46K | Buy |
59,309
+39,984
| +207% | +$3.68K | ﹤0.01% | 1147 |
|
2023
Q1 | $5.03K | Sell |
19,325
-1,820
| -9% | -$473 | ﹤0.01% | 1230 |
|
2022
Q4 | $4.44K | Buy |
+21,145
| New | +$4.44K | ﹤0.01% | 1255 |
|
2022
Q3 | – | Sell |
-13,510
| Closed | -$10K | – | 2130 |
|
2022
Q2 | $10K | Buy |
+13,510
| New | +$10K | ﹤0.01% | 1104 |
|
2019
Q1 | – | Sell |
-3,190
| Closed | -$7K | – | 1694 |
|
2018
Q4 | $7K | Buy |
+3,190
| New | +$7K | ﹤0.01% | 1088 |
|
2018
Q1 | – | Sell |
-701
| Closed | -$5K | – | 1790 |
|
2017
Q4 | $5K | Sell |
701
-487
| -41% | -$3.47K | ﹤0.01% | 993 |
|
2017
Q3 | $10K | Buy |
+1,188
| New | +$10K | ﹤0.01% | 822 |
|
2017
Q1 | – | Sell |
-1,341
| Closed | -$17K | – | 1208 |
|
2016
Q4 | $17K | Sell |
1,341
-613
| -31% | -$7.77K | 0.01% | 662 |
|
2016
Q3 | $36K | Buy |
+1,954
| New | +$36K | 0.01% | 577 |
|
2016
Q1 | – | Sell |
-752
| Closed | -$20K | – | 443 |
|
2015
Q4 | $20K | Buy |
+752
| New | +$20K | 0.02% | 206 |
|